摘要:
A new thiazolidine derivative of the formula: where n stands for an integer of 3 to 6 and salts thereof show strong aldose reductase inhibition and are useful for prophylaxis or therapy of diabetic cataract, diabetic neuropathy in mammals.
摘要:
A new thiazolidine derivative of the formula: where n stands for an integer of 3 to 6 and salts thereof show strong aldose reductase inhibition and are useful for prophylaxis or therapy of diabetic cataract, diabetic neuropathy in mammals.
摘要:
The present invention relates to a compound of the formula: wherein A is halogen, N(O)mR¹R², N ⊕ R¹R²R³·X ⊖ , S(O)nR¹ or S ⊕ (O)mR¹R²·X ⊖ where R¹,R² and R³ are each optionally substituted hydrocarbon or heterocyclic group, X ⊖ is a counter anion; m is an integer of 0 or 1; n is an integer of 0 to 2; R¹ and R² may form a nitrogen-containing or a sulfur-containing heterocyclic ring, which may further form a condensed ring, with the adjacent nitrogen atom or sulfur atom, and these nitrogen-containing or sulfur-containing heterocyclic rings may have substituents, B is O or NR⁴ where R⁴ is hydrogen or an optionally substituted lower alkyl or aryl group, D is 2-methyl-1-propenyl group or isobutyl group, and E is hydrogen, an optionally substituted hydrocarbon or an optionally substituted acyl group; provided that, when A is chlorine, E is an optionally substituted hydrocarbon or acyl excepting dinitrobenzoyl, a salt thereof, production and use thereof. The novel cyclohexanol derivatives of the present invention have angiogenesis inhibiting activity and anti-tumor activity, and they are used as anti-rheumatic agents, therapeutic agents of psoriasis, therapeutic agents of diabetic retinopathy and anti-tumor agents.
摘要:
The present invention relates to a compound of the formula: wherein R¹ is 2-methyl-1-propenyl group or isobutyl group; R² is hydrogen atom, an optionally substituted aliphatic hydrocarbon residue or an optionally substituted acyl group or a salt thereof. The compound (I) of the invention has, among others, angiogenesis inhibiting activity, cell-proliferation inhibiting activity and immune reaction inhibiting activity, thus being useful as medicines, etc.
摘要翻译:本发明涉及下式的化合物:其中R 1为2-甲基-1-丙烯基或异丁基; R 2是氢原子,任选取代的脂族烃残基或任选取代的酰基或其盐。 本发明的化合物(I)具有血管生成抑制活性,细胞增殖抑制活性和免疫反应抑制活性,因此可用作药物等。
摘要:
The present invention relates to a compound of the formula: wherein R¹ is 2-methyl-1-propenyl group or isobutyl group; R² and R³ are each hydrogen atom, an optionally substituted hydrocarbon residue or an optionally substituted acyl group or R² and R³ may form a ring together with the adjacent nitrogen atom; and the bonding mark ∼ means α-linkage or β-linkage, or a salt thereof. The compound (I) of the present invention has, among others, angiogenesis inhibiting activity, cell-growth inhibiting activity and immune reaction inhibiting activity, thus being useful as medicines, etc.
摘要翻译:本发明涉及下式的化合物:其中R 1为2-甲基-1-丙烯基或异丁基; R 2和R 3各自为氢原子,任选取代的烃残基或任选取代的酰基,或R 2和R 3可以与相邻的氮原子一起形成环; 并且粘合标记是指α-链接或β-连接,或其盐。 本发明的化合物(I)具有血管生成抑制活性,细胞生长抑制活性和免疫反应抑制活性,作为药物等有用。
摘要:
Fumagillin and its salts have an angiogenesis inhibiting activity and are useful for prophylaxis and treatment of diseases induced by abnormally stimulated neovascularization. The invention also provides certain pharmaceutical compositions comprising fumagillin or its salt, and an agent which potentiates angiogenesis inhibition such as heparin and sulfated cyclodextrins such as beta-cyclodextrin tetradecasulfate.
摘要:
A compound of the formula: (wherein R¹ is hydrogen or a lower alkyl) can be produced advantageously by (1) reacting a compound of the formula: (wherein R¹ has the meaning given above) with a halogenating agent or sulfonyl halide to give a compound of the formula: (wherein R¹ has the meaning given above and X is a halogen or an alkyl- or aryl-sulfonyloxy), (2) reacting the resulting compound with a compound of the formula: to give a compound of the formula: (wherein R¹ has the meaning given above), (3) reacting the resulting compound with a compound of the formula: to give a compound of the formula: (wherein R¹ has the meaning given above), and (4) subjecting the resulting compound to catalytic reduction.
摘要:
Thiazolidinedione derivatives of the formula: or pharmacologically acceptable salts thereof are novel compounds, which exhibit in mammals blood sugar- and lipid- lowering activity, and are of value as a therapeutic agent for diabetes and therapeutic agent for hyperlipemia.
摘要:
Fumagillin and its salts have an angiogenesis inhibiting activity and are useful for prophylaxis and treatment of diseases induced by abnormally stimulated neovascularization. The invention also provides certain pharmaceutical compositions comprising fumagillin or its salt, and an agent which potentiates angiogenesis inhibition such as heparin and sulfated cyclodextrins such as beta-cyclodextrin tetradecasulfate.